- Home
- GANX vs TPIC Comparison
GANX vs TPIC Comparison
Compare GANX & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- TPIC
- Stock Information
- Founded
- GANX 2017
- TPIC 1968
- Country
- GANX United States
- TPIC United States
- Employees
- GANX N/A
- TPIC N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- TPIC Industrial Machinery/Components
- Sector
- GANX Health Care
- TPIC Industrials
- Exchange
- GANX Nasdaq
- TPIC Nasdaq
- Market Cap
- GANX 51.8M
- TPIC 58.4M
- IPO Year
- GANX 2021
- TPIC 2016
- Fundamental
- Price
- GANX $1.44
- TPIC $0.75
- Analyst Decision
- GANX Strong Buy
- TPIC Hold
- Analyst Count
- GANX 5
- TPIC 7
- Target Price
- GANX $8.20
- TPIC $1.68
- AVG Volume (30 Days)
- GANX 275.2K
- TPIC 470.3K
- Earning Date
- GANX 08-11-2025
- TPIC 08-11-2025
- Dividend Yield
- GANX N/A
- TPIC N/A
- EPS Growth
- GANX N/A
- TPIC N/A
- EPS
- GANX N/A
- TPIC N/A
- Revenue
- GANX N/A
- TPIC $1,373,242,000.00
- Revenue This Year
- GANX N/A
- TPIC $10.73
- Revenue Next Year
- GANX N/A
- TPIC $5.56
- P/E Ratio
- GANX N/A
- TPIC N/A
- Revenue Growth
- GANX N/A
- TPIC 3.05
- 52 Week Low
- GANX $0.89
- TPIC $0.64
- 52 Week High
- GANX $3.19
- TPIC $5.15
- Technical
- Relative Strength Index (RSI)
- GANX 34.87
- TPIC 36.22
- Support Level
- GANX $1.55
- TPIC $0.85
- Resistance Level
- GANX $1.72
- TPIC $0.91
- Average True Range (ATR)
- GANX 0.12
- TPIC 0.07
- MACD
- GANX -0.02
- TPIC -0.00
- Stochastic Oscillator
- GANX 6.12
- TPIC 8.82
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.